简易筛查模型识别慢性疼痛阿片类药物使用者的睡眠呼吸暂停风险
本研究在199例因慢性疼痛使用阿片类药物的成人中,验证了由STOP-Bang问卷和日间静息SpO2组成的第一步筛查,联合家庭夜间血氧监测的简易模型。结果显示,以氧减指数≥5次/小时为阈值,该模型识别中重度睡眠呼吸暂停的敏感性为86.4%,特异性为52%,并使需要诊断性睡眠检查的人数从第一步到第二步减少了38%。
要点
- STOP-Bang评分≥3或日间静息SpO2≤95%可筛选出需进一步夜间血氧监测的高危患者。
- 夜间血氧氧减指数≥5次/小时识别中重度睡眠呼吸暂停的敏感性86.4%、特异性52%。
- 该两步模型可使需诊断性睡眠检查的人数减少38%。
核心结论
- 由STOP-Bang问卷和日间静息SpO2组成的第一步筛查,联合夜间血氧监测,可识别慢性疼痛阿片类药物使用者中中重度睡眠呼吸暂停的高危人群。
研究设计与样本
- 研究纳入199例因慢性疼痛使用阿片类药物的成人,年龄52.5±12.8岁,女性占58%。
- 参与者完成STOP-Bang问卷、日间静息SpO2及实验室多导睡眠监测,并在家进行夜间血氧监测以得出氧减指数。
- 以多导睡眠监测的呼吸暂停低通气指数≥15次/小时为标准,验证夜间血氧氧减指数的筛查效能。
主要发现
- 159例(79.9%)STOP-Bang评分≥3或日间静息SpO2≤95%,进入第二步夜间血氧监测。
- 以氧减指数≥5次/小时为阈值,模型识别中重度睡眠呼吸暂停的敏感性为86.4%,特异性为52%。
- 从第一步到第二步,需要诊断性睡眠检查的人数减少了38%。
关键数值与推荐
- 第一步高风险阈值:STOP-Bang评分≥3或日间静息SpO2≤95%。
- 第二步夜间血氧氧减指数阈值:≥5次/小时。
- 参考标准:多导睡眠监测呼吸暂停低通气指数≥15次/小时定义中重度睡眠呼吸暂停。
临床怎么用
- 对慢性疼痛长期使用阿片类药物的患者,可先用STOP-Bang问卷和日间静息SpO2进行初筛。
- 初筛高风险者建议进行家庭夜间血氧监测,氧减指数≥5次/小时者进一步行诊断性睡眠检查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is an increased risk of sleep apnea in patients using opioids for chronic pain. We hypothesized that a simple model comprizing of: (1) STOP-Bang questionnaire and resting daytime oxyhemoglobin saturation (SpO2); and (2) overnight oximetry will identify those at risk of moderate-to-severe sleep apnea in patients with chronic pain. METHOD: Adults on opioids for chronic pain were recruited from pain clinics. Participants completed the STOP-Bang questionnaire, resting daytime SpO2, and in-laboratory polysomnography. Overnight oximetry was performed at home to derive the Oxygen Desaturation Index. A STOP-Bang score ≥3 or resting daytime SpO2 ≤95% were used as thresholds for the first step, and for those identified at risk, overnight oximetry was used for further screening. The Oxygen Desaturation Index from overnight oximetry was validated against the Apnea-Hypopnea Index (≥15 events/hour) from polysomnography. RESULTS: Of 199 participants (52.5±12.8 years, 58% women), 159 (79.9%) had a STOP-Bang score ≥3 or resting SpO2 ≤95% and entered the second step (overnight oximetry). Using an Oxygen Desaturation Index ≥5 events/hour, the model had a sensitivity of 86.4% and specificity of 52% for identifying moderate-to-severe sleep apnea. The number of participants who would require diagnostic sleep studies was decreased by 38% from Step 1 to Step 2 of the model. CONCLUSION: A simple model using STOP-Bang questionnaire and resting daytime SpO2, followed by overnight oximetry, can identify those at high risk of moderate-to-severe sleep apnea in patients using opioids for chronic pain. TRIAL REGISTRATION NUMBER: NCT02513836.
引用
- Selvanathan J, Waseem R, Peng P, et al. Simple screening model for identifying the risk of sleep apnea in patients on opioids for chronic pain. Reg Anesth Pain Med. 2021. PMID: 34373347. doi:10.1136/rapm-2020-102388
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。